[{"id":"e4e5b5ae-4209-402e-817d-04b5df309c96","acronym":"ON-5001","url":"https://clinicaltrials.gov/study/NCT06022029","created_at":"2023-09-01T17:11:43.841Z","updated_at":"2024-07-02T16:35:12.473Z","phase":"Phase 1","brief_title":"A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.","source_id_and_acronym":"NCT06022029 - ON-5001","lead_sponsor":"OncoNano Medicine, Inc.","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Libtayo (cemiplimab-rwlc) • ONM-501"],"overall_status":"Recruiting","enrollment":" Enrollment 168","initiation":"Initiation: 10/13/2023","start_date":" 10/13/2023","primary_txt":" Primary completion: 04/30/2026","primary_completion_date":" 04/30/2026","study_txt":" Completion: 08/29/2026","study_completion_date":" 08/29/2026","last_update_posted":"2024-03-28"}]